Publikationen, an denen er mitarbeitet Ana Maria Hurtado Lopez (7)

2020

  1. Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach

    OncoImmunology, Vol. 9, Núm. 1

2019

  1. Increasing therapy-related myeloid neoplasms in multiple myeloma

    European Journal of Clinical Investigation, Vol. 49, Núm. 2

2018

  1. An early increase of CD56 bright natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease

    Transfusion, Vol. 58, Núm. 12, pp. 2924-2932

  2. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups

    International Journal of Laboratory Hematology, Vol. 40, Núm. 5, pp. 549-555

  3. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia

    British Journal of Haematology, Vol. 182, Núm. 3, pp. 373-383

2016

  1. Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: Kinetics, clinical impact and absence of STAT3 mutations

    British Journal of Haematology, Vol. 172, Núm. 6, pp. 937-946

2015

  1. Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia

    Blood Cancer Journal, Vol. 5